cefixime has been researched along with Bronchitis in 17 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Bronchitis: Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The bacteriological eradication rates of Streptococcus pneumoniae from sputum of patients experiencing acute exacerbations of chronic bronchitis (WHO definition) have been compared following therapy with either cefuroxime axetil 250 mg b." | 9.09 | Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime. ( Geslin, P; Leblanc, F; Petitpretz, P; Rio, Y; Zuck, P, 1999) |
| "9) suffering from bacterial exacerbation of chronic bronchitis have been randomly treated: 79 with co-amoxiclav (amoxicillin 875 mg+clavulanic acid 125 mg) twice daily, 69 with cefixime (400 mg) once daily, and 70 with ciprofloxacin (500 mg) twice daily for an average period of 10 days." | 9.08 | Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis. ( Beghi, GF; Casalini, A; Cazzola, M; Consigli, GF; Fiorentini, F; Giura, R; Madonini, V; Paizis, G; Tonna, M; Vinciguerra, A, 1995) |
| "The focus of a multicenter trial conducted in Germany was to investigate whether a 5-day short course of cefixime 400 mg was equivalent to a 10-day standard therapy of cefixime 400 mg in the treatment of acute exacerbation of chronic bronchitis (AECB)." | 9.08 | Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis. ( Lorenz, J, 1998) |
| "Patients with purulent exacerbation of chronic bronchitis were randomized to receive either a single 400-mg daily dose of cefixime or 250 mg of cephalexin, orally, four times a day." | 9.06 | Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis. ( Kalbfleisch, JH; Roberson, D; Sarubbi, F; Verghese, A, 1990) |
| " The antibiotic was given at a dosage of 200 mg b." | 6.67 | [Clinical experiences with cefixime in the treatment of bacterial infections of the lower respiratory tract]. ( Kersten, W; Müsken, H, 1990) |
| "The bacteriological eradication rates of Streptococcus pneumoniae from sputum of patients experiencing acute exacerbations of chronic bronchitis (WHO definition) have been compared following therapy with either cefuroxime axetil 250 mg b." | 5.09 | Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime. ( Geslin, P; Leblanc, F; Petitpretz, P; Rio, Y; Zuck, P, 1999) |
| "9) suffering from bacterial exacerbation of chronic bronchitis have been randomly treated: 79 with co-amoxiclav (amoxicillin 875 mg+clavulanic acid 125 mg) twice daily, 69 with cefixime (400 mg) once daily, and 70 with ciprofloxacin (500 mg) twice daily for an average period of 10 days." | 5.08 | Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis. ( Beghi, GF; Casalini, A; Cazzola, M; Consigli, GF; Fiorentini, F; Giura, R; Madonini, V; Paizis, G; Tonna, M; Vinciguerra, A, 1995) |
| " We have investigated the impact on normal human intestinal flora in a 10-day course with cefetamet-pivoxil (CET, 500 mg BID) in comparison to cefixime (CFX, 400 mg qD) or cefuroxime axetil (CA, 250 mg BID) in 24 patients suffering from acute exacerbation of chronic bronchitis." | 5.08 | Betalactam therapy and intestinal flora. ( Cassetta, MI; Conti, S; Dei, R; Fallani, S; Mazzei, T; Novelli, A, 1995) |
| "The focus of a multicenter trial conducted in Germany was to investigate whether a 5-day short course of cefixime 400 mg was equivalent to a 10-day standard therapy of cefixime 400 mg in the treatment of acute exacerbation of chronic bronchitis (AECB)." | 5.08 | Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis. ( Lorenz, J, 1998) |
| "Patients with purulent exacerbation of chronic bronchitis were randomized to receive either a single 400-mg daily dose of cefixime or 250 mg of cephalexin, orally, four times a day." | 5.06 | Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis. ( Kalbfleisch, JH; Roberson, D; Sarubbi, F; Verghese, A, 1990) |
| "In a pilot study with a limited number of patients the efficacy and tolerance of cefixime, a new oral cephalosporin antibiotic, were investigated in 15 children with the clinical diagnosis of bacterial respiratory tract infection, otitis media or urinary tract infection." | 3.68 | [Therapy of pediatric infections with cefixime]. ( Helwig, H, 1990) |
| " The antibiotic was given at a dosage of 200 mg b." | 2.67 | [Clinical experiences with cefixime in the treatment of bacterial infections of the lower respiratory tract]. ( Kersten, W; Müsken, H, 1990) |
| " The mean half-life and the mean AUC values were 2." | 1.27 | [Pharmacokinetics and clinical effects of cefixime in pediatrics]. ( Ishimoto, K; Koga, T; Motohiro, T; Nagayama, K; Nishiyama, T; Shimada, Y; Tanaka, K; Tominaga, K; Tomita, S; Yamashita, F, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (35.29) | 18.7374 |
| 1990's | 10 (58.82) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brückner, O | 1 |
| Trautmann, M | 1 |
| Catena, E | 1 |
| Mistretta, A | 1 |
| Micillo, E | 1 |
| Crimi, N | 1 |
| Dericoloso, L | 1 |
| Tranchese, D | 1 |
| Barbagallo, S | 1 |
| Marcos Sánchez, F | 1 |
| Reinoso Cobo, D | 1 |
| García Camba, L | 1 |
| Celdrán Gil, JL | 1 |
| Nouvet, G | 1 |
| Benmessaoud, K | 1 |
| Cazzola, M | 1 |
| Vinciguerra, A | 1 |
| Beghi, GF | 1 |
| Paizis, G | 1 |
| Giura, R | 1 |
| Madonini, V | 1 |
| Fiorentini, F | 1 |
| Consigli, GF | 1 |
| Tonna, M | 1 |
| Casalini, A | 1 |
| Novelli, A | 1 |
| Mazzei, T | 1 |
| Fallani, S | 1 |
| Dei, R | 1 |
| Cassetta, MI | 1 |
| Conti, S | 1 |
| Lorenz, J | 1 |
| Al-Eidan, FA | 1 |
| McElnay, JC | 1 |
| Scott, MG | 1 |
| Kearney, MP | 1 |
| Troughton, KE | 1 |
| Jenkins, J | 1 |
| Zuck, P | 1 |
| Petitpretz, P | 1 |
| Geslin, P | 1 |
| Rio, Y | 1 |
| Leblanc, F | 1 |
| Kersten, W | 1 |
| Müsken, H | 1 |
| Helwig, H | 1 |
| Verghese, A | 1 |
| Roberson, D | 1 |
| Kalbfleisch, JH | 1 |
| Sarubbi, F | 1 |
| Mikawa, H | 1 |
| Mayumi, M | 1 |
| Akiyama, Y | 1 |
| Ito, S | 1 |
| Watanabe, Y | 1 |
| Kanaoka, H | 1 |
| Takeshita, S | 1 |
| Takahashi, Y | 1 |
| Akiyama, F | 1 |
| Yoshimura, T | 1 |
| Iwata, S | 1 |
| Yokota, T | 1 |
| Kusumoto, Y | 1 |
| Shiro, H | 1 |
| Sato, Y | 1 |
| Akita, H | 1 |
| Nanri, S | 1 |
| Oikawa, T | 1 |
| Ishikawa, K | 1 |
| Kumagai, N | 1 |
| Furukawa, S | 1 |
| Okada, T | 1 |
| Motohiro, T | 1 |
| Tanaka, K | 1 |
| Koga, T | 1 |
| Shimada, Y | 1 |
| Tomita, S | 1 |
| Nishiyama, T | 1 |
| Ishimoto, K | 1 |
| Tominaga, K | 1 |
| Yamashita, F | 1 |
| Nagayama, K | 1 |
9 trials available for cefixime and Bronchitis
| Article | Year |
|---|---|
Comparative study of efficacy and safety of ciprofloxacin and cefixime in the treatment of acute exacerbations of chronic bronchitis after first-line treatment failure. French Study Group.
Topics: Aged; Anti-Infective Agents; Bronchitis; Cefixime; Cefotaxime; Chronic Disease; Ciprofloxacin; Drug | 1995 |
Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combinati | 1995 |
Betalactam therapy and intestinal flora.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria, Anaerobic; Br | 1995 |
Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis.
Topics: Administration, Oral; Bronchitis; Cefixime; Cefotaxime; Cephalosporins; Chronic Disease; Cost-Benefi | 1998 |
Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchit | 1999 |
Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime.
Topics: Adult; Aged; Aged, 80 and over; Bronchitis; Cefixime; Cefuroxime; Cephalosporins; Chronic Disease; D | 1999 |
[Clinical experiences with cefixime in the treatment of bacterial infections of the lower respiratory tract].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Bronchopneu | 1990 |
Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Bronchitis; Cefixime; Cefotaxime; Cephalexin; Chronic Disease; Gram-Negative Bacteria | 1990 |
[Clinical studies on cefixime in pediatrics].
Topics: Adolescent; Bacterial Infections; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Ev | 1989 |
8 other studies available for cefixime and Bronchitis
| Article | Year |
|---|---|
Efficacy and safety in the oral treatment of purulent chest disease and pneumonia with cefixime, ofloxacin, and ciprofloxacin.
Topics: Administration, Oral; Anti-Bacterial Agents; Bronchitis; Cefixime; Ciprofloxacin; Clinical Trials as | 1989 |
Cefixime: comparative clinical trial on the treatment of lower respiratory tract infection in adults.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bronchitis; Bronchopneumonia; Cefixime; Cephalexin; Clinic | 1989 |
[Cefixime in the treatment of lower respiratory tract infections in patients with chronic bronchitis].
Topics: Aged; Anti-Infective Agents; Bronchitis; Cefixime; Cefotaxime; Chronic Disease; Drug Tolerance; Huma | 1995 |
[Direct costs to primary care of chronic bronchitis. Analysis of a prospective study].
Topics: Aged; Anti-Bacterial Agents; Bronchitis; Cefixime; Chronic Disease; Cohort Studies; Direct Service C | 2001 |
[Therapy of pediatric infections with cefixime].
Topics: Anti-Infective Agents; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Humans; Lymphadeni | 1990 |
[The effect of cefixime (CFIX) on intestinal bacterial flora].
Topics: Bronchitis; Bronchopneumonia; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Resistance, Microb | 1986 |
[Clinical experience with cefixime in the pediatric infections].
Topics: Acute Disease; Adolescent; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Half-L | 1986 |
[Pharmacokinetics and clinical effects of cefixime in pediatrics].
Topics: Acute Disease; Adolescent; Bacterial Infections; Bronchitis; Cefixime; Cefotaxime; Child; Child, Pre | 1986 |